Product Description
Probiotics From Kimchi (CJLP243) for Bowel Function Restoration After Ileostomy Closure In Patients With Rectal Cancer (Sourced from: https://clinicaltrials.gov/ct2/history/NCT02751736?V_2=View)
Mechanisms of Action: Unknown
Novel Mechanism: No
Modality: N/A
Route of Administration: N/A
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Seoul National University Hospital
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|---|---|---|---|---|
| B-1603-339-003 | N/A |
Unknown status |
Colorectal Cancer |
2017-12-01 |